Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 12 studies | 77% ± 17% | |
type II pneumocyte | 12 studies | 97% ± 6% | |
club cell | 7 studies | 77% ± 34% | |
epithelial cell | 5 studies | 46% ± 30% | |
endothelial cell of lymphatic vessel | 4 studies | 44% ± 31% | |
ionocyte | 4 studies | 39% ± 31% | |
basal cell | 4 studies | 51% ± 22% | |
ciliated cell | 4 studies | 39% ± 12% | |
T cell | 3 studies | 56% ± 30% | |
alveolar macrophage | 3 studies | 26% ± 15% | |
monocyte | 3 studies | 52% ± 34% | |
fibroblast | 3 studies | 47% ± 25% | |
respiratory goblet cell | 3 studies | 58% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 9 studies | 36% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 491829.16 | 577 / 578 | 73% | 3594.57 | 846 / 1155 |
thymus | 100% | 14863.40 | 651 / 653 | 61% | 744.90 | 371 / 605 |
kidney | 96% | 241.57 | 85 / 89 | 3% | 3.81 | 24 / 901 |
stomach | 62% | 107.59 | 221 / 359 | 0% | 0.59 | 1 / 286 |
heart | 56% | 98.28 | 483 / 861 | 0% | 0 | 0 / 0 |
esophagus | 51% | 54.14 | 741 / 1445 | 1% | 7.07 | 2 / 183 |
adrenal gland | 52% | 61.93 | 134 / 258 | 0% | 0 | 0 / 230 |
peripheral blood | 51% | 162.05 | 477 / 929 | 0% | 0 | 0 / 0 |
prostate | 51% | 47.76 | 125 / 245 | 0% | 0 | 0 / 502 |
pancreas | 50% | 54.71 | 164 / 328 | 0% | 0 | 0 / 178 |
intestine | 49% | 62.21 | 478 / 966 | 0% | 1.11 | 2 / 527 |
muscle | 49% | 79.49 | 397 / 803 | 0% | 0 | 0 / 0 |
adipose | 48% | 91.50 | 582 / 1204 | 0% | 0 | 0 / 0 |
ovary | 46% | 860.51 | 82 / 180 | 0% | 0.29 | 2 / 430 |
liver | 46% | 71.72 | 104 / 226 | 0% | 0 | 0 / 406 |
breast | 46% | 59.32 | 210 / 459 | 0% | 0.08 | 1 / 1118 |
blood vessel | 45% | 105.15 | 598 / 1335 | 0% | 0 | 0 / 0 |
brain | 44% | 57.90 | 1163 / 2642 | 0% | 0 | 0 / 705 |
uterus | 43% | 38.17 | 73 / 170 | 1% | 0.84 | 3 / 459 |
spleen | 42% | 43.95 | 102 / 241 | 0% | 0 | 0 / 0 |
skin | 40% | 77.97 | 729 / 1809 | 1% | 20.83 | 7 / 472 |
bladder | 10% | 3.29 | 2 / 21 | 7% | 463.98 | 33 / 504 |
lymph node | 0% | 0 | 0 / 0 | 3% | 2.18 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006665 | Biological process | sphingolipid metabolic process |
GO_0007585 | Biological process | respiratory gaseous exchange by respiratory system |
GO_0009887 | Biological process | animal organ morphogenesis |
GO_0045334 | Cellular component | clathrin-coated endocytic vesicle |
GO_0097486 | Cellular component | multivesicular body lumen |
GO_0097208 | Cellular component | alveolar lamellar body |
GO_0005764 | Cellular component | lysosome |
GO_0005576 | Cellular component | extracellular region |
GO_0042599 | Cellular component | lamellar body |
GO_0005771 | Cellular component | multivesicular body |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | SFTPB |
Protein name | Pulmonary surfactant-associated protein B (Pulmonary surfactant-associated proteolipid SPL(Phe)) Surfactant protein B Pulmonary surfactant-associated protein B (SP-B) (18 kDa pulmonary-surfactant protein) (6 kDa protein) (Pulmonary surfactant-associated proteolipid SPL(Phe)) |
Synonyms | SFTP3 |
Description | FUNCTION: Pulmonary surfactant-associated proteins promote alveolar stability by lowering the surface tension at the air-liquid interface in the peripheral air spaces. SP-B increases the collapse pressure of palmitic acid to nearly 70 millinewtons per meter. FUNCTION: Pulmonary surfactant-associated proteins promote alveolar stability by lowering the surface tension at the air-liquid interface in the peripheral air spaces. SP-B increases the collapse pressure of palmitic acid to nearly 70 millinewtons per meter. . |
Accessions | P07988 ENST00000428225.5 U3KQT2 ENST00000393822.7 ENST00000409383.6 ENST00000519937.7 H0Y7V6 ENST00000494165.1 |